Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

High-dose corticosteroid therapy following portoenterostomy in infants with biliary atresia does not improve outcome: The multi-center, randomized, double-blind, placebo-controlled START Trial

Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS, Erlichman J, Haber B, Hertel PM, Karpen SJ, Kerkar N, Loomes KM, Molleston JP, Murray KF, Romero R, Schwarz KB, Shepherd R, Suchy FJ, Turmelle YP, Whitington PF, Moore J, Sherker AH, Robuck PR, Sokol RJ. High-dose corticosteroid therapy following portoenterostomy in infants with biliary atresia does not improve outcome: The multi-center, randomized, double-blind, placebo-controlled START Trial. Proceedings of American Association for the Study of Liver Diseases (AASLD) 64th Annual Meeting; November 1, 2013; Washington, D.C. 2013 Nov.

Public Release Type: Conference Presentation
Publication Year: 2013
Authors: Suchy FJ, Sokol RJ, Robuck PR, Sherker AH, Moore J, Whitington PF, Turmelle YP, Shepherd R, Schwarz KB, Romero R, Murray KF, Molleston JP, Loomes KM, Kerkar N, Karpen SJ, Hertel PM, Haber B, Erlichman J, Wang KS, Rosenthal P, Shneider BL, Magee JC, Spino C, Bezerra JA
Studies: A Prospective Database of Infants With Cholestasis , ChiLDReN Network , Steroids in the Treatment of Biliary Atresia

Home chevron_right Publications chevron_right High-dose corticosteroid therapy following portoenterostomy in infants with biliary atresia does not improve outcome: The multi-center, randomized, double-blind, placebo-controlled START Trial

High-dose corticosteroid therapy following portoenterostomy in infants with biliary atresia does not improve outcome: The multi-center, randomized, double-blind, placebo-controlled START Trial

Abstract